In Vitro Complement-Binding on Cytoplasmic Structures in Normal Human Skin: I. Immunofluorescence Studies  by Hintner, H. et al.
0022-202X/82/7902-0119$02.00/ 0 
THE JOURNAL OF INVESTlGA'I' IV E DERMATOLOGY, 79: 119- 124, 1982 
Co py right © 1982 by The Willi ams & Wilkjns Co. 
Vol. 79, No.2 
Printed ill. U.S.A. 
In Vitro Complement-Binding on Cytoplasmic Structures in Normal 
Human Skin: I. Immunofluorescence Studies 
H. HINTNER, G. STINGL, G. SCHULER, AND K. WOLFF 
Department of Dermatology, University of Innsbruch, lnnsbruck, A ustria (HH,GSch) and Departm.ent of Derm.atology I, University of 
Vienna, Vienna, A ustria (GSt, KH-] 
Incubation of cryostat sections of normal human skin 
with normal human serum (NHS) at 37 °C followed by 
fluorescein isothiocyanate labeled rabbit antihuman C3 
(FITC-R/H u-C3) yields cytoplasmic staining of various 
cell types including k eratinocytes of the upper epidermal 
layers, melanocytes, fibroblasts, smooth muscle cells, 
and cells lining vascular structures. 
Deposition of C3 on the respective cytoplasmic struc-
tures is most likely due to activation of the classical 
complement (C) cascade on these structures since no 
fluorescent staining is observed when serum of patients 
with hereditary C4-deficiency is used instead of NHS or 
when incubation with NHS is performed in the presence 
of EDTA or EGTA in concentrations known to inhibit 
classical C pathway activation. Further evidence sug-
gesting the involvement of the classical C pathway 
comes from the finding that incubation of cryostat skin 
sections with NHS followed by FITC labeled rabbit an-
tihuman Clq (FITC-R/Hu-Clq) results in a fluorescent 
staining pattern remarkably similar to that seen after 
exposure of cryostat skin sections to NHS and FITC-R/ 
Hu-C3. 
Although formal proof is lacking, our investigations 
strongly indicate that binding to and activation of C 
components on cytoplasmic structures occur indepen-
dently of the presence of circulating antibodies. This 
assumption is based on the finding that in 17 out of 20 
NHS we were not able to detect any skin reactive anti-
bodies by indirect immunofluorescence (IF) techniques. 
More conclusive evidence for a direct, antibody-indepen-
dent interaction between C components and cytoplasmic 
structures is provided by the observation that incubation 
of the substrate with purified Clq followed by FITC-R/ 
Hu-Clq results in cytoplasmic staining of some of the 
skin cell populations described above. 
The phenomenon of C-binding and activation on cyto-
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plasmic structures of normal human skin cells may be a 
critical event in the initiation of complement mediated 
pathophysiological reactions of the skin. 
Immune complex-triggered activation of the complement cas-
cade leads to t he formation of biologically active fragments 
which have the capacity to bind to cell surface receptor sites 
specific for a particular fmgment (reviewed in reference 1). 
More recent evidence indicates that the binding of Clq to cells 
or cell constit uents may occur independently of its previous 
interaction with complexed antibody in that for example unal-
tered Clq may directly bind to bacterial lipopolysaccharides 
[2], the envelope of oncorna vimses [3], heart subcellular mem-
branes [4], glutaraldehyde-treated red cells [5], sm face antigens 
of Trypanosoma brucei [6] and DNA [7]. Recently, Linder and 
co-workers have presented evidence which indicates that C-
activation can occur on cytoplasmic structures of various cell 
types including cytoskeletal intermediate-sized filaments of cul-
tmed human embryonal fibroblasts and human fetal connective 
t issue [8], of muscle cells and vascular endothelium [9,10]. 
In the present study we have obtained evidence with the use 
of IF techniques that components of the classical C-pathway 
can be demonstrated in an intracytoplasmic location on cryostat 
sections of normal human skin previously exposed to fresh 
NHS. Cell types exhibiting th e C-fixing structmes include ker-
atinocytes of the upper epidermal layers, melanocytes, fibro-
blasts, endothelial cells and smooth muscle cells. For at least 2 
cell populations, i.e., keratinocytes of the upper epidermal lay-
ers and smooth muscle cells, we have suggestive evidence that 
Clq, after binding to cytoplasmic structures, init iates the acti-
vation of the classical C pathway and that this event can occur 
independently of an tibody activity. 
MATERIALS 
Sow'ces of ant isera and reagents: FITC-R/Hu-C3, FITC-labeled 
rabbit antiserum against human IgA or fibrinogen (all sera F / I' ratio 
2,3; DAKO antibody t itre 100 /-Lg/ ml) : Dako Immunoglobulins, Copen-
hagen, Denmru·k. 
FITC-H/Hu-Clq (F / P ratio 1,7; 12 ± 5 mg/mJ protein with 10 ± 5% 
specific antibody content) and an t isheep erytru'ocyte antibodies: Beh-
ringwerke AG , Mro'bmg, FRG. FITC-labeled rabbit antiserum against 
human IgG (F/ I' ratio 3,5; 1,7 mg antibody/ml) or IgM (F/ P ratio 3,4; 
1,5 mg an t ibody/mil : Kent Laboratories Ltd" North Vancouver, BC, 
Canada. 
Chemicals: Tissue-T ek II O.C.T. compound: Lab-Tek Products, 
Division Miles Laboratories Inc., Naperville, TIl. Ethidium bromide and 
EGTA: Sigma Chemical Co., St. Louis, Mo. E DTA: Tit.riplex III, Merck, 
Dru'mstadt, FRG. Immunodiffusion plates: Quantiplate, Biotest-Serum-
Institute GmbH, Frankfurt, FHG. Functionally purified C-components: 
Cordis Laboratories, Miami, Fla. Disposable dermatome: Davol Inc., 
Providence, RI. Cryo-cut microtome: American Optical Corporation. 
Fluorescent microscope: OrthopJan Universelles Gro,Bfeldmikroskop, 
Leitz, Wetzlru·. 
METHODS 
Normal human skin was obtained from 10 healthy donors by punch 
biopsy or with the aid of a disposable dermatome following local 
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anesthesia with 2% lidocaine. The skin specimens were embedded in 
T issue-Tek II O.C.T. compound, snap frozen in liquid ni trogen and 
stored at -70°C until sectioning. 4 p.m cryostat sections were ail'-dried 
for 20 min and then washed in phosphate buffered saline (PBS), pH 
7.3, for 10 min. Skin sections were then incubated for 30 min at 37°C 
with a t10 dilution of either freshly drawn human serum or samples 
which had been stored at -70°C and thawed immediately before use. 
Sera from 20 normal healthy individuals and from 2 patients with 
hereditary deficiency of the 4th component of C were used. Evidence 
for the complete absence of C4 in the respective sera was obtained by 
single radial immunodiffusion [11] using commercially available im-
munodiffusion plates and a hemolytic assay as described by Lachman 
and Hobart [12] using antisheep erythl'ocyte antibodies and function-
ally pUl'ified complement components. 
After wash ing 3 times in PBS for 10 min, the specimens were 
overlayered with FITC-R/Hu-C3 or FITC-R/Hu-Clq for 30 min at 
37°C. After rinsing the slides with PBS three times for )0 min , they 
were mounted with glycerine/PBS (4:1) and viewed under a flu orescent 
microscope equipped for incident illumination. In order to better dis-
tinguish the dermal-epidermal junction and thus to determine whether 
stained cells at the junction were intraepidermal or in the dermis, 
nucleax counterstaining was performed with 0.001% ethidium bromide. 
For controls, test sera were substituted by PBS. For the detection of 
cil'culating antibodies possibly directed against cytoplasmic antigens in 
various skin cells, FITC-Iabeled rabbit-antihuman immunoglobulin or 
FITC-labeled rabbit antihuman fibrinogen were used following the 
incubation with 1:5 or 1:10 diluted NHS. 
In several experiments purified Clq in a concentration of 100 p.g/ml 
was used in a first incubation period followed by FITC-R/Hu-Clq. The 
Clq component was isolated from fTesh normal human serum by a 
slight modification [13] of the method described by Volanakis and 
Stroud [14]. Briefly, the purification procedure consists of 2 successive 
precipitation steps at low ionic strength in the presence of EDTA in 
o'rder to dissociate Cll' and Cis. 10 ml of 0.1 M EDTA, pH 7.5, were 
added to 40 ml of fresh human serum. After incubation at 37°C for 10 
min the serum was chilled to O°C and 200 ml of 0.005 M EDTA were 
added slowly. The mixture was allowed to stand at 0-3°C for 1 hI' with 
occasional stirring. The resulting precipitate was recovered by centrif-
ugation at 12,000 g for 30 min, washed twice with 0.022 M EDT A, pH 
7.5 and dissolved in 1Q tnl 0.75 M NaCI, 0.01 M EDTA, pH 5.0. T his 
solution was stored for 18 hI' at 4°C and then centrifuged at 30,000 g for 
30 min at 4°C ·to remove insoluble materia l. The supel'J1atant was 
dialyzed for 4 ill against 2 changes of 0.067 M EDT A, pH 5.0. T he 
resu lting precipitate was collected by centrifugation at 12,000 g for 30 
min, washed twice with 20 ml dialyz ing buffer and then dissolved in 3 
ml 0.3 M NaCl, 0.01 M EDTA, pH 7.5. After a 2-hr incu bation at 4°C, 
insoluble aggregates were removed by centrifugation at 30,000 g for 30 
min at 4°C. After determination of the protein concentration, the 
presence of detectable amounts of immunoglobulins was excluded by 
Ouchterlony immunodiffusion techniques [151-
In order to obtain information about a possible activation of the 
classical complement pathway after binding of Clq, test sera were 
treated with either EDTA or EGTA in a fina l concentration of 10 mM. 
This concentration of EDTA is known to block both the classical and 
the altel'J1ative C-pathway; 10 mM EGTA has been shown to inhibit 
only the classical C-pathway [16]. 
RESULTS 
Detection of Skin-reactive Circulating Antibodies in Normal 
Human Sera 
When cryostat sections from normal human skin were over-
layered with a 1:5 dilution of any of the 20 test sera obtained 
from healthy individuals and. then reacted with FITC-Iabeled 
antisera to human IgG, a homogenous cytoplasmic staining of 
keratinocytes in the upper epidermal layers was seen with 3 of 
the test sera. This positive reactivity seen in th e epidermis 
contrasted with a complete lack of staining within the dermis. 
The staining pattern observed was indistinguishable from tha t 
described by other authors [17-19] and confirms their obser-
vation that certain normal human sera may contain antibodies 
directed against antigenic determinants present in the cyto-
plasm of keratinocytes in the upper layers of the epidermis (U-
Cyt antigens). This U-Cyt reactivity was not detected when 
NHS was replaced by PBS, or when the incubation with NHS 
was followed by antisera to human IgM, IgA or fibrinogen. 
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Detection of C3- binding Sites in Normal Human Shin 
The incubation of cryostat sections of normal human skin 
with all normal human sera tested followed by FITC-R/Hu-C3 
revealed bright cytoplasmic staining of different cell types 
within the epidermis and dermis. Virtually no fluorescent stain-
ing was seen when skin sections exposed to NHS were first 
incubated with unlabeled R/Hu-C3 before being reacted with 
FITC-R/Hu-C3. Keratinocytes of the upper epidermal layers 
displayed an homogenous, occasionally granular , strong cyto-
plasmic fluorescence, whereas nuclei, intercellular spaces and 
basal cell layers were consistently devoid of staining (Fig la 
and b) . In addition, there was a very distinct cytoplasmic 
staining of cells displaying a polygonal or dendl'itic shape within 
the dermis. These cells were particularly abundant in the 
papillary dermis (Fig Ib), whereas in the deeper layers t hey 
were more sparse and scattered between bundles of connective 
tissue (Fig lc). On the basis of distribution and shape, these 
cells were considered to represent fibroblasts. A third popula-
tion of cells within normal human skin, the smooth muscle cells 
of musculi arrectores pilorum, also displayed bright cytoplasmic 
fluorescence (Fig 2a). Preliminary immunoelectron microscopic 
studies confll'med the intracytoplasmic binding of C3 in the 
t/U'ee described cell populations and suggested that in termedi-
ate-sized filaments are the C-binding cytoplasmic structures 
(Schuler et al, manuscript in preparation) . 
Whereas the reactivity of the cytoplasm of these 3 cell types 
was detected consistently after incubation with each of t he 20 
normal test sera, positive staining of certain other cell types 
was observed only in a few instances. With 2 of the sera tested, 
a group of dendrit ic cells with bright cytoplasmic fluorescence 
was seen along the dermal-epidermal junction (Fig 3a). COUl1-
terstaining of tissue sections with ethidium bl'omide revealed 
that these dendritic cells were located within the basal layer of 
the epidermis; they were therefore considered to represent 
melanocytes (Fig 3b) and, indeed, the melanocyte natm e of 
these cells has been confll'med by preliminary immunoelectron 
microscopic investigations (Schuler et ai, manuscript in prepa-
ration) . In addition, a cytoplasmic staining of cells along vas-
cular structures was seen with eight of the test sera. D ue to the 
limitations of immunohistologic techniques we were not able to 
determine whether positively stained cells in the vicinity of or 
along vascular structUl'eS represented endothelial cells, smooth 
muscle cells within the vessel wall or pericytes (Fig Id). 
These results suggested, but did not prove, that C3 deposit ion 
on cytoplasmic structures of different cell types can occur in 
the absence of circulating antibodies. When sera from patients 
with hereditary C4-deficiency were used instead of normal 
human sera, FITC-R/Hu-C3 failed to stain th e cytoplasmic 
structures in question (Fig 4). This finding suggested that C3 
deposition on the respective structures is a consequence of 
classical C pathway activation. The validity of this assumption 
was further substantiated by our finding that in the presence of 
EDTA or EGTA in the test sera at concentrations (10 mM) 
which allow blockade of the classical C pathway no staining 
reaction with FITC-R/Hu-C3 was disclosed. In control sections, 
when test sera were replaced by PBS, no specific reactivity was 
detected . 
Detection of Clq-binding Sites in Normal Human S lzin 
The incubation of tissue sections with either NHS or purified 
Clq followed by FITC-R/Hu-Clq led in both instances to iden-
tical results: Strong cytoplasmic staining within keratinocytes 
of the upper epidermal layers (Fig 5a) and within smooth 
muscle cells of musculi arrectores pilo)'um (Fig 2b) , indistin-
guishable from that seen with FITC-R/HlI-C3 was observed. 
However, within the dermis, a staining pattern was revea led 
which slightly differed from .that seen after incubation wi th 
FITC-R/HlI-C3. Although cells, displaying a polygonal and 
freq uently dendl'itic shape were clearly visualized, they were 
diffusely scattered within the dermis (Fig 5b) and were not 
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FIG 1. Cryostat sections of normal human skin were incubated with NHS and in a second incubation period exposed to FITC-R/ Hu-C3: (a) 
Bright cytoplasmic staining of kerat inocytes of the upper epidermal layers is seen. Nuclei and intercellular spaces as well as basal epidermal cell 
layers are devoid of staining. The dermal-epidermal junction is marked by white arrows. Note (lower left corner) one cell in the papillary dermis 
with bright cytoplasmic staining including dendrit ic processes (x 220). (b) In addit ion to t.he staining of upper epidermal keratinocytes highly 
dendri tic cells clustered in the papillary dennis (fibroblasts) exhibi t a strong cytoplasmic staining (x 220). (e) High-power magnification of brightly 
s ta ined dendritic dermal cells scattered between bundles of connective tissue (x 440) . (d) Cytoplasmic staining of cells out lining a medium-sized 
dermal vessel (x 440). 
FI G 2. a., Cryostat skin sections were exposed to NHS and then to FITC-R/ Hu-C3: bright sta ining of cross or oblique cut musculi arrectores 
pilorum is seen (x 220). b, T issue specimens were first incubated with purified Clq and then wi th FITC-R/ Hu-Clq: an identical staining pattern 
as that seen in Fig 2a is disclosed (x 220) . 
122 HINTNER ET AL . Vol. 79, No.2 
FIG 3. a, Cryostat sections of normal human skin were incubated with NHS followed by FITC-R/Hu-C~:. Cells. with brigh t cytoplasmic 
flu orescence (marked by white arrows) are detected a long the dermal-epidermal junction (x 220). b, Counterstammg of cell nuclei with eLhldlum 
bromide reveals that ceUs described in Fig 3a are located within the basal ceU layer of the epiderm is (wlute arrows). B lacl1 (t./.,.ow~ mark the 
border between keratinocytes of the upper layers exhibiting cytoplasmic sta ining and unstained basal kera tmocytes (x 220) . 
FIG 4. A no, mal human skin cryostat specimen was incubated with 
the serum of a patient with hereditary C4 deficiency and then with 
FITC-R/ Hu-C3: no specific sta ining within the epidermis or dermis is 
seen (x 90) . 
clustered along the dermal-epidermal junction as were the cells 
identified by FITC-R/Hu-C3. In addition, incubation with 
FITC-R/Hu-Clq disclosed a heavily stained cell population 
outlining vessel lumina which , most likely, represent endothelial 
cells (Fig 5b). Dendritic cells within the basal layers (melano-
cytes) escaped detection with any of the test sera or t issue 
sections employed. 
It must be mentioned at this point that both endothelial cells 
and a few polygonal cells randomly distributed within the 
dermis, but not epidermal cells or smooth muscle cells were 
also stained, when control tissue sections were initially exposed 
to PBS instead of NHS or purified Clq and then reacted with 
FITC-R/ Hu-Clq. 
DISCUSSION 
Using indirect IF techniques, Linder, Lehto, ano Stenman 
have recent ly been able to show that cytoplasmic structures, 
most likely intermediate-sized filaments, present in human 
embryonal fibroblasts [8], in the endothelia of vessel walls [9,10] 
as well as in various muscle cells [9,10], have the capacity to 
bind complement components Clq, C4 and C3 when exposed to 
NHS. Furthermore, these authors presen ted suggestive evi-
dence that binding of Clq to th e respective cytoplasmic struc-
tures is the initiating event for further activation of the classical 
C pathway. In this report, we have sem'ched for the presence of 
C-binding cytoplasmic structures in normal human skin and 
have made the following observations: 
1. Exposure of cryostat sections of normal human skin to 
fresh NHS leads to the binding of C3 to' cytoplasmic struct lll'es 
in suprabasal keratinocytes, fibroblasts and smooth muscle 
cells, frequently in cells associated with vascular structures and 
occasionally in melanocytes. 
2. This C3-binding appears to be due to the activation of the 
classical C cascade in that it cannot be detected when either C4 
deficient serum is used instead of NHS or when EGT A or 
EDT A at concentmtions which inhibit complement activation 
by chelating Ca++ and Mg++ m'e added to the test serum during 
incubation. 
3. Exposure of cryostat skin sections of normal skin either to 
fresh NHS or purified Clq followed by FITC-R/ Hu-Clq also 
reveals cytoplasmic staining of upper keratinocytes, dermal 
cells, smooth muscle cells of musculi arrectores pilorum and 
endothelial cells, whereas incubation with FITC-R/Hu-Clq 
alone stains only endothelial cells and some dermal cells. 
Among the cell types .having cytoplasmic C-binding struc-
tures, 2 virtually identical populations were identified either by 
the use of FITC-R/Hu-C3 or FITC-R / Hu-Clq, i.e., keratino-
cytes of the upper epidermal layers and smooth muscle cells 
within musculi arrectores pilorum. Our data strongly suggest 
that these cell populations possess cytoplasmic structures ca-
pable of antibody-independent binding of Clq and th at Clq 
binding initiates activation of the' classical C cascade. This 
conclusion is based on the following observations: (a) incubation 
of tissue sections with purified Clq followed by FITC-R/ H u-
Clq reveals staining which is not seen after incubation with 
FITC-R/ Hu-Clq alone (Fig 2b, Sa); (b) incubation of tissue 
sections with NHS or C4-deficient serum followed by FITC-R/ 
Hu-Clq gives an identical staining pattern; (c) incubation of 
tissue sections with NHS followed by FITC-R / Hu-C3 yields 
identical results whereas rep'lacement of NHS by C4-defi cient 
serum or performance of the IF assay in the presence of EG T A 
or EDT A yields negative results. 
The staining pattern observed in suprabasal keratinocytes 
remarkably resembled that seen when cryostat sections of 
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normal human skin are reacted in an indirect IF procedure with 
normal human sera containing IgG antibodies against upper 
epidermal cytoplasmic antigens as described by other authors 
[17-19]. One may therefore aJ'gue that the C3- and Clq-binding 
observed in the cytoplasm of these cells may be due to anti-
bodies directed against U-Cyt antigens which, because of a 
possible lack of sensitivity of the IF procedure, escape detection 
by incubation with FITC-anti-human IgG, but can be readily 
visualized by their C-binding capacity. Although we cannot 
absolu tely exclude this possibility, we have shown that purified 
Clq in the absence of serum binds to cytoplasmic structures 
within keratinocytes of the upper layers and within smooth 
muscle cells which demonstrates that the binding of the mole-
cule which initia tes classical complement activation can occur 
independently of the presence of antibodies. 
On the other hand, the consistent detection of C3 binding 
structmes within the cytoplasm of denru'itic fibroblasts of the 
papillary dermis (Fig 1b) and the occasional visualization of C3 
within melanocytes and endothelial cells of small and medium-
sized vessels may be due to a different mechanism. With all test 
sera and tissues used, hU'ge numbers of denru'itic fibroblasts 
located in the upper dermis and, thus, in close proximity to the 
dermal-epidermal junction were seen after incubation of tissue 
sections with NHS followed by FITC-R/Hu-C3 (Fig 1b). These 
cells were not seen under conditions which do not allow acti-
vation of the classical complement cascade which excludes the 
possibility that the C3 binding may have OCCUlTed directly or 
due to alternative pathway activation. Surprisingly, however, 
these fibroblasts in the papillary dermis partly escaped detec-
tion when tissue sections were exposed to either purified Clq or 
NHS followed by FITC-R/ Hu-Clq, although these reagents did 
reveal denru'itic cells in the lower dermis (Fig 5b). Similarly, 
the melanocyte fluorescence seen after incubation of skin sec-
tions with certain NHS and FITC-R/ Hu-C3 was oot observed 
when FITC-R/ Hu-C3 was replaced by FITC-R/ Hu-Clq. We 
offer 2 possible explanations for this phenomenon. On one hand, 
both fibroblasts in the papillary dermis and melanocytes may 
have cytoplasmic Clq receptors in such small quantities that 
they escape detection by conventional IF but yet suffice to 
initiate C-activation and thus result in large numbers of bound 
C3 molecules, which can, at least in some instances, then be 
visualized by IF. Alternatively, it is conceivable that virtually 
all normal individuals possess circulating antibodies dil'ected 
against cytoplasmic structures within fibroblasts which again-
due to the limitat ions of IF procedures-can only be detected 
by theil' C-binding properties. In the case of melanocytes, Hertz 
et al [20] demonstrated antibodies against cytoplasmic deter-
minants within melanocytes, nevus and melanoma cells in sera 
from 2 patients with a variety of autoimmune disorders via 
their C-fixing ability. It may well be that a few of om test sera 
also contained anti-melanocyte autoantibodies whose binding 
can only be visualized by their C-binding properties. 
A third interesting observation was made when tissue sec-
tions were incubated with FITC-R/ Hu-Clq alone. In tissue 
FIG 5. Cryostat skin sections are incubated first wi th purified Clq and then with FITC-R/ Hu-Clq: a, The cytoplasm of epidermal cells within 
the upper Malpighian layers is stained; nuclei, intercellular spaces and basal epidermal layers do not show any specific staining (x 220). b. 
Cytoplasmic staining of cells, some possessing dendritic processes, wi thin the reticular dermis. White arrows point to cell outlining vascular 
stw ctures (x 220). 
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sections from all 10 different donors, a strong fluorescence of 
endothelial cells within small to medium-sized vessels and 
certain cells scattered between collagen bundles of the dermis 
was seen. The entire epidermis and smooth muscle cells were 
completely negative. The most likely interpretation of this 
finding is that the respective cells represent sites of Clq synthe-
sis, or that complexed Clq has been taken up by those cells in 
vivo. This finding does not exclude the possibility that endo-
thelial cells also possess cytoplasmic C-binding structures, al-
though deposition of C3 within the cytoplasm of endothelial 
cells was not a regular finding and on a given substrate was 
only seen with 8 of 20 sera tested. Two possibilities may account 
for this finding. First, one might argue that Clq synthesized by 
endothelial cells does not initiate classical complement activa-
tion by itself but masks Clq binding structures to a varying 
extent thus allowing serum-derived Clq to bind and activate the 
classical C-cascade only in certain instances. This possibility is 
rather unlikely as the detection of cytoplasmic C3 binding was 
not substrate dependent but rather dependent upon the serum 
source used. Due to the careful handling of experimental serum 
samples, it appears unlikely that, as a consequence of degra-
dation processes, the amount of single complement components 
available became the limiting factor. Alternatively, the role of 
C-fixing autoantibodies for the generation of cytoplasmic C3 
binding within endothelial cells cannot be ruled out. Only 
recently it was reported that sera of patients with various 
inflammatory conditions contain antibodies which react with 
cytoskeletal intermediate-sized filaments of vascul:u endothe-
lial cells [21]. Although our sera were derived from healthy 
individuals, the presence of only minute amounts of such anti-
bodies in certain sera might suffice to allow their detection via 
their C-binding properties. 
Another rather surprising finding deserves to be discussed in 
greater detail. Although Clq is reported to bind to DNA [7], we 
did not observe nuclear fluorescence when skin sections were 
incubated with Clq, followed by FITC-R/Hu-Clq. Using Crith-
idia luciliae-a hemoflagellate which is widely used as a sub-
strate for determination of serum antibodies against double-
stranded DNA [22]-as a substrate, Linder [23] observed strong 
binding of Clq to kinetoplasts, (which consist essentially only of 
circular, double-stranded DNA) but only very slight Clq binding 
to Crithidia luciliae nuclei. These authors suggested that the 
lack of significant Clq binding to nuclei was due to a blocking 
of the Clq receptor on nuclear DNA by histones or other 
nuclear constituents. Although formal proof is lacking, this 
phenomeno~ may account for our inability to detect nuclear 
Clq binding. 
Certainly, the \ most important observation of this study is 
that cytoplasmic structures exist in certain skin cells (keratin-
ocytes, smooth muscle cells) which are capable of antibody-
independent binding of Clq. Although formal proof is lacking 
our data strongly indicate that the binding of Clq to these 
respective cytoplasmic structures results in the activation of 
the classical complement pathway. Cell injury, as a consequence 
of either physical trauma, limited vascular supply, infectious 
and toxic agents or metabolic and immunological disturbances, 
would expose these cytoplasmic structures to Clq present within 
the interstitial fluid. With the binding of Clq the classical C 
pathway would be activated leading to the generation of bio-
logically active split products of the C cascade. Since these 
peptides are mediators in a series of important biological mech-
anisms including immune adherence, acute inflammatory re-
spons.es and can interact with other protein systems [24], the 
presented phenomena of C-binding and activation on cytoplas-
mic structures of normal human skin cells may be a critical 
event in the initiation of reparative processes which utilize the 
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C-cascade and are operative in a variety of physiological and 
pathological processes affecting the skin. 
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